Executive interview – Verona Pharma

Executive interview – Verona Pharma

Verona Pharma’s chairman, Dr David Ebsworth, provides an overview of the group’s core technology and applications, corporate strategy and development plans for its lead product, RPL554. He also outlines expected near-term news flow and the regulatory strategy.


You may also be interested in these:

Investment Companies

IP Group - executive interview

Investment Companies

Oakley Capital Investments – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free